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▼One of the most accurate and reproducible quantitative
reverse transcription–polymerase chain reaction (RT–PCR)
techniques is the use of competitive systems with internal
RNA standards (Ref. 1, 2). Normally, the construction of in-
ternal RNA standards as competitor fragments is performed
by insertion or deletion within the wild-type template fol-
lowed by cloning into an appropriate vector (Ref. 3). Here,
we discuss the easy and fast construction of internal, re-
combinant RNA-fragments without the use of cloning tech-
niques. The method is a valid and reliable procedure for the
absolute quantification of small amounts of specific mRNA.
The only primers that are required are two additional ‘link-
ers’ that contain the sequence of the RNA polymerase pro-
moter (e.g. T7), those used for the wild-type gene mRNA
and those of a spacer gene. The internal standard RNA com-
petitors were constructed by a modified site-directed muta-
genesis procedure, as described by Fo¨rster et al. (Ref. 4).
The disadvantage of the co-amplification of a structurally
unrelated endogenous mRNA for a housekeeping gene is
circumvented by co-amplifying the native target mRNA to-
gether with known amounts of an internal standard cRNA
that shows identical primer binding sites. Both target and
standard RNA compete for the primers and reagents in the
same reaction tube. As a result, variations in amplification
efficiency affect both template and standard RNA similarly.
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Protocol
Two linker triple primers of approximately 60 bp were syn-
thesized and used for PCR amplification (Figure 1).
Primer A contained a partial sequence of the T7 pro-
moter, the target gene 5′ primer and a spacer gene 5′
primer (e.g. ribosomal protein L19). Primer B contained
a poly(dT) sequence on its 5′ end, the target gene 3′
primer and the spacer gene 3′ primer.
The amplicon was purified by agarose gel electrophore-
sis and purified using a PCR product purification kit
(Boehringer Mannheim). The resulting DNA standard
was transcribed into cRNA by a T7 RNA polymerase
(Boehringer Mannheim) and after DNase treatment the
purity of the cRNAwas confirmed by PCR amplification
without prior reverse transcription, thus demonstrat-
ing the absence of residual standard DNA construct.
Compared with the native sequence, the DNA con-
struct is flanked by the same primers that are used to
amplify the wild-type mRNA, but constitutes a longer
amplicon than the wild-type target mRNA.
The mRNA was quantified by co-amplifying target RNA af-
ter reverse transcription (RT) with defined amounts of
internal standard cRNA in the same tube to avoid varia-
tions in the RT efficiency. The resulting amplicons were
separated on an agarose gel and stained with ethidium
bromide. Both bands of interest, the standard and the
target, were scanned and quantified using a commer-
cial computer program for integrating intensity and
area [SigmaGel (Jandel Scientific, Erkrath, Germany)].
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FIGURE 1. Construction of the competitive cRNA standard. Reverse transcription–polymerase chain reaction (RT–PCR) of rat liver RNA using two
linker primers, one that contained a partial sequence of the spacer gene (e.g. ribosomal protein L19), a sequence of the target gene and a partial sequence
of the T7 RNA polymerase promoter at its 5′ end, and one that contained a partial sequence of the spacer gene, a sequence of the target gene and a
poly(dT)-tail at its 5′ end, resulting in a 223 bp sequence instead of a 159 bp sequence for the endothelial constitutive nitric oxide synthase (ecNOS) wild
type. After purification of the resulting PCR product, an in vitro transcription using T7 RNA polymerase was performed using a thermal cycler.
FIGURE 2. Competitive co-amplification of standard and target RNA by reverse transcription–polymerase chain reaction (RT–PCR). After the indicated
cycle numbers, PCR products were analyzed and number of cycles were plotted versus the ratio of standard PCR product and target PCR product. The
ratio remained constant throughout the different cycles, indicating equal reaction efficiencies for both standard and target in this range of cycles.
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FIGURE 3. Linearity between the input of total RNA into the reverse transcription–polymerase chain reaction (RT–PCR) and the measured amount of
endothelial constitutive nitric oxide synthase (ecNOS) mRNA molecules.
The yields of the two products were compared by plotting
their ratio of standard PCR product to target PCR prod-
uct (r) against the amount of internal standard used in
the RT–PCR on the x-axis. The ratio plot was extrapo-
lated to r=1, which is the ratio of equal molar amounts
of target and standard PCR products that gives the ini-
tial amount of target mRNA. Depending on the results
of the initial titration assay, the number of dilution se-
ries had to be adapted to the particular expression level
of the target RNA. For routine comparisons, five stan-
dard concentrations of a dilution series were used in 1:2
steps. Kinetic analysis of competitive co-amplification
of wild-type and internal standard amplicons was per-
formed (Figure 2).
The sensitivity of the RT–PCR assay was evaluated using
different starting amounts of cRNA from 0.25 fg to
80 pg. Using the UV–ethidium-bromide-gel detection
scheme, the minimal detectable amount of cRNA was
approximately 1 fg (∼6500molecules) per reaction tube
(50 µl). The linearity of the RT–PCR assay was deter-
mined by quantifying the mRNA in serial dilutions of
an RNA preparation containing 0.5 µg, 1 µg, 1.5 µg
and 2 µg of total RNA. Each RNA dilution was assayed
together with a dilution series of the cRNA standard.
As an example, the quantity of endothelial constitu-
tive nitric oxide synthase (ecNOS)mRNA could be plot-
ted against the total RNA input into the RT–PCR assay
(Figure 3). A linear relationship between the amount
of total RNA input and the measured mRNA concen-
tration could thus be demonstrated. To confirm the
reproducibility of the competitive RT–PCR, the assay
variation was determined. Five identical RT–PCR exper-
iments were performed, each with 0.5µg total RNA and
an identical dilution series of the cRNA standard. Quan-
tification of ecNOS resulted in 3.48 ± 0.19 × 107 mRNA
molecules and thus in an assay variation of 5.46%.
The technique for the generation of internal cRNA
standards that is described here has several advantages
compared with cloning techniques: (1) the technique
only requires standard PCR equipment and no fur-
ther cloning; (2) the generation of the internal RNA
standard can be completed within one day; and (3)
the in vitro transcription using T7 RNA polymerase is
very efficient (e.g. input of 1.5 µg of DNA standard
results in an output of approximately 10 µg cRNA).
The ratio between target and standard PCR products
remains constant throughout the amplification. Thus,
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we have shown that the present mRNA quantification
is not necessarily limited to the exponential phase but
is also reliable in the plateau phase of PCR. By em-
ploying this technique, we have been able to observe
obviously good assay variations of ∼5.5%. To date we
have applied this method successfully to quantify ec-
NOS, inducible NOS (iNOS), migration inhibitory fac-
tor (MIF), insulin-like growth factor (IGF) and IGF-
receptor mRNA, respectively.
In conclusion, our data on sensitivity, linearity and re-
producibility demonstrate that the described compet-
itive RT–PCR assay allows the relatively easy, accurate
and absolute quantification of mRNA with a high sen-
sitivity even for tissues, where the RNA is of low abun-
dance. Because all of the steps of the procedure can be
performed by commercially available kits, the method
outlined above can be used easily even in laboratories
with little experience in molecular biology.
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Products Used
PCR product Purification kit: PCR product Pu-
rification kit from Boehringer Mannheim
T7 RNA polymerase: T7 RNA polymerase from
MBI Fermentas
T7 RNA polymerase: T7 RNA polymerase from
Boehringer Mannheim
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